| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.27B | 251.37B | 226.71B | 228.06B | 207.97B | 209.12B |
| Gross Profit | 121.47B | 116.54B | 104.78B | 106.80B | 101.09B | 87.75B |
| EBITDA | 76.02B | 74.55B | 66.11B | 67.84B | 64.45B | 55.97B |
| Net Income | 45.35B | 43.04B | 38.03B | 41.09B | 38.78B | 33.47B |
Balance Sheet | ||||||
| Total Assets | 322.24B | 330.76B | 323.46B | 298.71B | 279.69B | 265.51B |
| Cash, Cash Equivalents and Short-Term Investments | 34.27B | 27.45B | 22.74B | 29.65B | 34.66B | 32.38B |
| Total Debt | 26.10B | 40.47B | 40.98B | 27.29B | 22.71B | 22.67B |
| Total Liabilities | 80.87B | 94.58B | 92.56B | 77.19B | 71.68B | 64.95B |
| Stockholders Equity | 238.01B | 233.29B | 227.47B | 218.42B | 205.91B | 198.83B |
Cash Flow | ||||||
| Free Cash Flow | 45.87B | 43.01B | 12.70B | 15.05B | 29.10B | 30.40B |
| Operating Cash Flow | 61.74B | 59.18B | 33.70B | 35.23B | 41.95B | 39.94B |
| Investing Cash Flow | -18.65B | -17.61B | -18.74B | -19.64B | -12.39B | -12.85B |
| Financing Cash Flow | -39.60B | -35.65B | -22.10B | -25.03B | -27.87B | -25.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥747.86B | 16.62 | 19.69% | 3.15% | 10.06% | 18.03% | |
72 Outperform | ¥1.23T | 115.13 | 1.67% | 1.00% | -1.90% | -71.97% | |
71 Outperform | ¥799.82B | 19.79 | 4.79% | 4.21% | -1.21% | -27.21% | |
68 Neutral | ¥1.31T | 11.96 | 1.09% | 3.50% | -11.50% | 25.86% | |
66 Neutral | ¥793.83B | 9.36 | 8.79% | 2.68% | -1.64% | ― | |
62 Neutral | ¥512.18B | 66.07 | 1.08% | 3.37% | -1.94% | -84.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Nissan Chemical Corporation has continued its share repurchase program, buying 340,000 common shares on the Tokyo Stock Exchange between December 1 and December 31, 2025, at a total cost of approximately 1.8 billion yen. This transaction forms part of a broader board-approved buyback plan, under which the company is authorized to repurchase up to 2.5 million shares or 9 billion yen through March 31, 2026; as of December 31, 2025, it had cumulatively acquired about 1.41 million shares for roughly 6.8 billion yen, signaling an ongoing effort to enhance capital efficiency and return value to shareholders.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6081.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation reported a 10.1% increase in net sales for the six months ending September 30, 2025, compared to the same period in the previous year. The company’s financial results indicate a positive trajectory with increased net income and a revised dividend outlook, suggesting strengthened financial health and potential benefits for stakeholders.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5791.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.
Nissan Chemical Corporation announced the cancellation of 1,000,000 of its common shares, representing 0.73% of its issued shares, as decided in a Board of Directors meeting. This move is part of the company’s capital management strategy, potentially impacting shareholder value and market perception by reducing the number of outstanding shares.
The most recent analyst rating on (JP:4021) stock is a Buy with a Yen6140.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.